NEW YORK, Sept. 29, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a cutting-edge biotechnology company focused on developing innovative therapies for neurodegenerative diseases ...
In the first episode of Emergency NYC, Dr. Langer operates on a 29-year-old opera singer who had a stroke at a wedding. It’s all in a day’s work for Langer, a graduate of the University of ...
Decoy’s development of novel peptide-conjugate therapeutics arising from its proprietary IMP3ACT™ platform to benefit from Dr. Langer’s extensive scientific knowledge and experience CAMBRIDGE, Mass.
SCHENECTADY, N.Y. (NEWS10) — As COVID-19 cases continue to surge and recede around the country, the co-founder of the company behind one of the vaccines spoke at Union College Wednesday evening. Dr.
CAMBRIDGE, Mass. and HOUSTON, April 16, 2025 (GLOBE NEWSWIRE) -- Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results